You are here

Imagin Medical Inc.

Imagin Medical Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Technology
Symbol: 
IME
CSE Index: 
Currency: 

Imagin Medical is Building a Best-in-Class Urologic Oncology Company Developing technologies to better visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery

The Company believes its first product, the i/Blue Imaging System™, with its advanced proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease.

Imagin’s follow-on product, the enCAGE Coil™ is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.

After receipt of FDA clearance, Imagin believes the enCAGE Coil system for Prostate Cancer will address the limitations of current forms of treatment by enabling the surgeon to preset precise margins to target only the cancer cells, avoiding damage to the remaining prostate gland and surrounding erectile nerves that can impair urinary and sexual function.

Imagin’s proprietary technologies are poised to expand patient access and improve outcomes and quality of life.

You are here

Imagin Medical Inc. (IME)

SEDAR Information

Company Info

Address
890 West Pender St., Suite 600
Vancouver, BC V6C 1J9
Canada
Phone
833-246-2446
Email
jvacha@imaginmedical.com
Website
http://www.imaginmedical.com
Listing date
Wednesday, February 24, 2016
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
John Vacha
Email
jvacha@imaginmedical.com
Auditor
De Visser Gray

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
10,830,116
Reserved for Issuance: 
26,519,687

Company Officers

E. James Hutchens, President & CEO
John Vacha, Chief Financial Officer (CFO)

Bulletins

26/10/2020

2020-1035 – Consolidation - Imagin Medical Inc. (IME)

Le 26 octobre/October 2020

Imagin Medical Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common shares for every twenty (20) pre-consolidation common shares.

As a result, the outstanding shares of the company will be reduced to approximately 8,917,013 common shares

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

TAKESTOCK - Calgary Investor Forum

TAKESTOCK - Calgary Investor Forum

Wednesday, June 7, 2023 -
9:00am to 5:00pm
Summit on Responsible Investment

Summit on Responsible Investment

Tuesday, June 27, 2023 -
9:00am to 7:00pm